Eaton Apothecary Selects Predictive Acquisition Cost (PAC) Drug Price Type

Eaton Apothecary Selects Predictive Acquisition Cost (PAC) Drug Price Type PR Newswire TAMPA, Florida, June 28, 2012 TAMPA, Florida, June 28, 2012 /PRNewswire/ -- Holliston, Mass.-based pharmacy chain selects PAC from Elsevier / Gold Standard and Glass Box Analytics Leading drug information provider, Elsevier / Gold Standard, announced today that Holliston, Mass.-based pharmacy chain Eaton Apothecary has purchased the new Predictive Acquisition Cost (PAC), developed by Glass Box Analytics and exclusively sold by Elsevier / Gold Standard. Introduced earlier this year, PAC is a new drug price type that more closely tracks true acquisition cost. PAC employs predictive analytics techniques to estimate acquisition cost considering various factors, including MAC benchmarks, published price lists, existing price benchmarks, drug dispensing metrics, supply-demand measures, and survey-based acquisition costs. Independent tests show that PAC tracks drug acquisition cost with sufficient accuracy to support pricing activity. "Glass Box Analytics has done an exceptional job developing the new price type, PAC," said Eaton Apothecary Vice President of Operating Policy John H. Lynch, III. "We are eager to begin using PAC for our company and look forward to the growth potential the new tool will offer as we integrate its intelligence into our existing systems." Eaton Apothecary has 16 locations, including traditional retail pharmacies and those focused on home delivery and specialized care.